View our peptide treatment plans to see all available protocol options at Perfect B Side Effects and Safety: How the Two Protocols Compare Both tesamorelin and CJC-1295/Ipamorelin have well-characterized safety profiles when prescribed and monitored by a licensed provider
In-vitro work also explores its interaction with growth-factor receptors and its effects on cell migration and proliferation in wound-model assays
CJC-1295 and ipamorelin are commonly used together because they have complementary time-release characteristics: CJC-1295 is effectively GHRH that has been modified to have a longer half-life, so it stimulates pituitary growth hormone secretion in a sustained manner over an extended period.9 Ipamorelin acts on the pituitary gland directly, inducing a more immediate dump of growth hormone into circulation
The glucagon receptor activation at 8mg and above drives significant lipolysis and fat oxidation, which, combined with adequate protein intake and resistance training , may preserve lean tissue better than lower doses
Important Information For research and professional use only
While some healthcare providers continue to prescribe compounded peptides, the FDA peptide warning maintains that patients should be aware of the uncertainties surrounding these products and the potential risks associated with their use